Areas of interest
General molecular biology, gene expression, cell based assays, in situ hybridization, bioinformatics, statistics.
Andy Cassidy graduated from Swansea University in 1987 with a degree in microbiology and worked for several years as a research technician at Warwick and Manchester Universities before joining a small start up company set up by Leicester University (the company offered contract immunohistochemistry and in situ hybridisation services to biotech and pharmaceutical companies). He subsequently joined the pharmaceutical industry (AstraZeneca) in 1997 and spent 10 years in the Cancer & Infection Dept. as a Senior Scientist using transcriptomics to investigate tumour biology before moving into assays and High Content Screening. After leaving pharma, and prior to joining the LSTM, he completed a short post at Cancer Research UK (Cambridge) as a Senior Scientific Officer delivering an in situ hybridization service to the institute.
Since joining the LSTM in 2013 he has been working as part of the Anti-Wolbachia (AWOL) consortium using high content analysis cell based assays to screen compound libraries for potential therapeutic agents to combat tropical filariasis.